Get the Stockscreener App
21.19
9.33%
-2.18
After Hours:
21.16
-0.03
-0.14%
Progyny Inc stock is traded at $21.19, with a volume of 3.49M.
It is down -9.33% in the last 24 hours and down -6.07% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.37
Open:
$22.77
24h Volume:
3.49M
Relative Volume:
2.32
Market Cap:
$1.99B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
33.63
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-8.78%
1M Performance:
-6.07%
6M Performance:
+27.57%
1Y Performance:
-34.80%
1-Day Range:
$20.35
$22.80
1-Week Range:
$20.35
$23.77
52-Week Range:
$13.39
$30.42
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.19 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny, Inc. (NASDAQ:PGNY) Q1 2025 Earnings Call Transcript - Insider Monkey
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised - Yahoo Finance
Earnings call transcript: Progyny Q1 2025 beats EPS estimates By Investing.com - Investing.com India
Progyny, Inc. Reports Strong Q1 2025 Results - TipRanks
Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Yahoo Finance
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Earnings call transcript: Progyny Q1 2025 beats EPS estimates - Investing.com
Progyny: Q1 Earnings Snapshot - Norwalk Hour
Progyny Q1 2025 Earnings Call Transcript - MarketBeat
Progyny, Inc. Announces First Quarter 2025 Results - GlobeNewswire
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Progyny Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Progyny, Inc. Q1 Profit Beats Estimates - Nasdaq
Progyny (PGNY) Surpasses Q1 Revenue Expectations with Robust Growth | PGNY Stock News - GuruFocus
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next Quarter - Yahoo Finance
(PGNY) PROGYNY INC. Forecasts Q2 Revenue Range $310M$325M - marketscreener.com
Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Progyny (PGNY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
BlackRock, Inc. Adjusts Holdings in Progyny Inc: A Strategic Portfolio Move - GuruFocus
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - ADVFN
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Progyny: Q3 Earnings Snapshot - marketscreener.com
At US$22.90, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely? - simplywall.st
Progyny, Inc. Announces Details for Its First Quarter 2025 Resul - GuruFocus
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report - The Manila Times
Progyny, Inc. to Report Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Progyny Sets Date for Q1 2025 Earnings: What Fertility Healthcare Investors Should Watch - Stock Titan
(PGNY) Technical Data - news.stocktradersdaily.com
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Progyny Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Progyny Rings the Opening Bell - Nasdaq
Progyny names Melissa Cummings as COO - MSN
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product - GuruFocus
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny Names Melissa Cummings COO - marketscreener.com
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief - GlobeNewswire
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - TradingView
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week® | PGNY Stock News - GuruFocus
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.95%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):